UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000011713
Receipt number R000013694
Scientific Title A phase II study of Bevacizumab plus Docetaxel for advanced large cell neuroendocrine carcinoma (LCNEC) with previously treated with platinum based chemotherapy
Date of disclosure of the study information 2013/09/12
Last modified on 2013/09/11 19:56:27

No. Disposal Last modified on Item of update
1 Insert 2013/09/11 19:57:02